Comment
doi: 10.1038/ejhg.2008.222.
Epub 2008 Nov 26.
Unraveling hyperlipidemia type III (dysbetalipoproteinemia), slowly
- PMID: 19034315
- PMCID: PMC2986265
- DOI: 10.1038/ejhg.2008.222
Item in Clipboard
Comment
Unraveling hyperlipidemia type III (dysbetalipoproteinemia), slowly
Eur J Hum Genet.
2009 May.
No abstract available
Comment on
-
The expression of type III hyperlipoproteinemia: involvement of lipolysis genes.Eur J Hum Genet. 2009 May;17(5):620-8. doi: 10.1038/ejhg.2008.202. Epub 2008 Nov 26. Eur J Hum Genet. 2009. PMID: 19034316 Free PMC article.
Similar articles
-
The expression of type III hyperlipoproteinemia: involvement of lipolysis genes.Eur J Hum Genet. 2009 May;17(5):620-8. doi: 10.1038/ejhg.2008.202. Epub 2008 Nov 26. Eur J Hum Genet. 2009. PMID: 19034316 Free PMC article.
-
The D9N, N291S and S447X variants in the lipoprotein lipase (LPL) gene are not associated with Type III hyperlipidemia.BMC Med Genet. 2007 Aug 29;8:56. doi: 10.1186/1471-2350-8-56. BMC Med Genet. 2007. PMID: 17727701 Free PMC article.
-
Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects.J Lipid Res. 1996 Feb;37(2):309-19. J Lipid Res. 1996. PMID: 9026529
-
Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).Ric Clin Lab. 1982 Jan-Mar;12(1):23-30. Ric Clin Lab. 1982. PMID: 6283616 Review. No abstract available.
-
[Interaction between genes and diet as a determinant of the plasma levels of cholesterol].Med Clin (Barc). 1998 Oct 31;111(14):546-51. Med Clin (Barc). 1998. PMID: 9859082 Review. Spanish. No abstract available.
Cited by
-
Modern prevalence of dysbetalipoproteinemia (Fredrickson-Levy-Lees type III hyperlipoproteinemia).Arch Med Sci. 2019 Aug 2;16(5):993-1003. doi: 10.5114/aoms.2019.86972. eCollection 2020. Arch Med Sci. 2019. PMID: 32863987 Free PMC article.
-
Impaired LDL receptor-related protein 1 translocation correlates with improved dyslipidemia and atherosclerosis in apoE-deficient mice.PLoS One. 2012;7(6):e38330. doi: 10.1371/journal.pone.0038330. Epub 2012 Jun 6. PLoS One. 2012. PMID: 22701627 Free PMC article.
-
Modern prevalence of the Fredrickson-Levy-Lees dyslipidemias: findings from the Very Large Database of Lipids and National Health and Nutrition Examination Survey.Arch Med Sci. 2019 Aug 3;16(6):1279-1287. doi: 10.5114/aoms.2019.86964. eCollection 2020. Arch Med Sci. 2019. PMID: 33224326 Free PMC article.
-
The Genetic Basis of Hypertriglyceridemia.Curr Atheroscler Rep. 2021 Jun 19;23(8):39. doi: 10.1007/s11883-021-00939-y. Curr Atheroscler Rep. 2021. PMID: 34146174 Free PMC article. Review.
-
Eruptive xanthomas as a marker for metabolic disorders: A specific form of xanthoma that reflects hypertriglyceridemia.Clin Case Rep. 2022 Apr 21;10(4):e05671. doi: 10.1002/ccr3.5671. eCollection 2022 Apr. Clin Case Rep. 2022. PMID: 35474985 Free PMC article.
References
-
- Morganroth J, Levy RI, Fredrickson DS. The biochemical, clinical, and genetic features of type III hyperlipoproteinemia. Ann Intern Med. 1975;82:158–174. - PubMed
-
- Utermann G, Hees M, Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature. 1977;269:604–607. - PubMed
-
- Schaefer JR, Sattler AM, Hackler B, et al. Hyperlipidemia in patients with apolipoprotein E 2/2 phenotype: apolipoprotein A5 S19W mutation as a cofactor. Clin Chem. 2004;50:2214. - PubMed
-
- Evans D, Seedorf U, Beil FU. Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia. Clin Genet. 2005;68:369–372. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
